Menu
+
+
+
+
+
+
Suzhou Kintor Pharmaceuticals Inc. (Suzhou, China) and Suzhou Zelgen Biopharmaceuticals Co. Ltd. (Suzhou, China) each completed financings, raising more than $100 million combined.
Kintor raised RMB288 million ($44.7 million) on Jan. 11 in a series C round led...
BioCentury employs a fully integrated multimedia platform — including publications, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.
